CDH2 and esophageal squamous cell carcinoma: In another study, according to the expression level and localization of E-cadherin, Vimentin and N-cadherin, approximately 43% of the ESCC primary tumors and 53% of ESCC metastatic lymph nodes were classified as having a pEMT phenotype 41.